Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Head injury, Loss of consciousness, Loss of personal independence in daily activities, Malaise, Nausea
Clinical narrative: orthostatic syncope/ultimately passing out/multiple episodes of passing out/feeling sick, nausea, autonomic, neurological/fainting episodes/, seizure-like symptoms; autoimmune, autonomic, and neurological injuries; lives in fear constantly of having another fainting episode; bruising on her body from falling; hit her head; wake up in the middle of the night; diarrhea; exhaustion; Information has been received from a lawyer regarding a case in litigation and referred to a currently adult female patient (pt) (exact age not provided). Her other medical history, concurrent conditions and concomitant therapies were not provided. On 27-OCT-2020 (at the age of 15 years old), the pt was vaccinated with the first dose of quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL) intramuscular injection (exact dose, route of administration, anatomical location, lot # and expiration date were not provided), as recommended by her health care provider, with her mother's consent for prophylaxis (reported as for preventing cancer). On 18-JAN-2021, the pt was vaccinated with the second dose of quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL) intramuscular injection (exact doses, route of administration, anatomical locations, lots # and expiration dates were not provided). On 10-AUG-2021 (at the age of 16 years old), the pt was vaccinated with the third dose of quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL) intramuscular injection (exact dose, route of administration, anatomical location, lot # and expiration date were not provided) under recommendation of her health care provider. After receiving the third dose of quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL) vaccination, the patient started waking up in the middle of the night feeling sick (Middle insomnia), needing to go to the bathroom, and then ultimately passing out. She had multiple episodes of passing out where she hit her head and had bruising on her body from falling (Head injury; Contusion). She often had to miss school after an episode due to exhaustion (Fatigue). As the months progressed, so did patient's injuries. She continued to have fainting episodes, nausea, diarrhea, and seizure-like symptoms. As a result of her post-quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL) symptoms, patient had been unable to engage in activities that a normal young person would enjoy. She had to stop playing sports such as volleyball, basketball, and tracked to the extent she had before and had to turn down multiple college scholarships. Her grades suffered. Her life changed drastically from how she slept to how she got out of bed, what foods she could eat, and the amount of water she must drink. She now lived in fear constantly of having another fainting episode (Fear of disease). Based upon her chronic and severe post-quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL) symptoms, the patient had been diagnosed with various medical conditions, including but not limited to, orthostatic syncope. The patient contended that her quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL) injections caused her to develop serious and debilitating autoimmune, autonomic, and neurological, injuries, including but not limited to orthostatic syncope, as well as a constellation of adverse symptoms, complications, injuries, and other adverse events, many of which are alleged herein and all of which were caused by quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL) or otherwise linked to her quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL)-induced autoimmune disorder. As a proximate result of company's wrongful acts and breaches of warranties concerning the safety and efficacy of quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL), the patient had suffered and continued to suffer severe and permanent physical injuries, and associated symptomology and had suffered severe and permanent emotional injuries, including pain and suffering. The patient also had a substantial fear of suffering additional and ongoing harms, including but not limited to now being at an increased risk of cancer, and future symptoms and harms associated with her injuries caused by quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL). As a direct and proximate result of her quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL)-induced injuries, the patient had suffered and continued to suffer economic losses, including considerable financial expenses for medical care and treatment, and diminished income capacity and she would continue to incur these losses and expenses in the future. Patent' mother would never have consented to the patient receiving quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL), had she been adequately informed about the questionable efficacy and serious risks associated with quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL). The outcome of all events was considered to be not recovered. The lawyer considered all events to be related to quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL).  The lawyer considered all events to be disabling.  Upon internal review, the events of orthostatic syncope, autoimmune disorder were determined as medically significant.